Prognostic Impact of Reduced Left Ventricular Ejection Fraction After Endovascular Therapy for Lower Extremities
Keiko Fukino1, Daisuke Ueshima2, Tetsuo Yamaguchi3
1The Third Department of Internal Medicine, Teikyo University Chiba Medical Center.
Insights
Low left ventricular ejection fraction (LVEF) independently predicts adverse outcomes in lower-extremity artery disease (LEAD) patients undergoing endovascular therapy (EVT). Managing cardiac dysfunction is key to improving prognosis after EVT.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Interventional Cardiology
Background:
- The prognostic implications of heart failure in patients with lower-extremity artery disease (LEAD) undergoing endovascular therapy (EVT) remain unclear.
- Left ventricular ejection fraction (LVEF) is a critical indicator of cardiac function.
- This study investigates the impact of LVEF on outcomes in LEAD patients treated with EVT.
Purpose of the Study:
- To determine the prognostic significance of left ventricular ejection fraction (LVEF) in patients with lower-extremity artery disease (LEAD) undergoing endovascular therapy (EVT).
- To assess whether low LVEF independently predicts major adverse cardiovascular and cerebrovascular events (MACCEs) and major adverse limb events (MALEs).
Main Methods:
- A cohort of 2,180 patients with LEAD undergoing EVT between August 2014 and August 2016 was analyzed.
- Patients were stratified into low-LVEF (LVEF <40%) and not-low LVEF groups.
- Independent predictors of MACCEs and MALEs were identified using multivariable analysis.
Main Results:
- The low-LVEF group had a higher prevalence of heart failure, diabetes, chronic kidney disease, and critical limb ischemia.
- Low LVEF was independently associated with an increased incidence of MACCEs (HR: 2.23) and MALEs (HR: 1.85).
- The association between low LVEF and adverse events was consistent, irrespective of symptomatic heart failure status.
Conclusions:
- Low left ventricular ejection fraction (LVEF), rather than symptomatic heart failure alone, significantly increases the risk of MACCEs and MALEs in LEAD patients post-EVT.
- Optimizing cardiac dysfunction management may be crucial for improving the prognosis of patients with LEAD undergoing EVT.
Background:
The mechanism underlying a poor prognosis in patients with lower-extremity artery disease (LEAD) with heart failure is unknown. We examined the prognostic impact of the left ventricular ejection fraction (LVEF) in patients with LEAD who underwent endovascular therapy (EVT).
Methods And Results:
From August 2014 to August 2016, 2,180 patients with LEAD (mean age, 73.2 years; male, 71.9%) underwent EVT and were stratified into low-LVEF (LVEF <40%; n=234, 10.7%) and not-low LVEF groups. In the low- vs. not-low LVEF groups, there was a higher prevalence of heart failure (i.e., history of heart failure hospitalization or New York Heart Association functional class III or IV symptoms) (44.0% vs. 8.3%, respectively), diabetes mellitus, chronic kidney disease, below-the-knee lesion, critical limb ischemia, and incidence of major cardiovascular and cerebrovascular events (MACCEs) and major adverse limb events (MALEs) (P<0.001, all). Low LVEF independently predicted MACCEs (hazard ratio: 2.23, 95% confidence interval: 1.63-3.03; P<0.001) and MALEs (hazard ratio: 1.85, 95% confidence interval: 1.15-2.96; P=0.011), regardless of heart failure (P value for interaction: MACCEs: 0.27; MALEs: 0.52).
Conclusions:
Low LVEF, but not symptomatic heart failure, increased the incidence of MACCEs and MALEs. Intensive cardiac dysfunction management may improve LEAD prognosis after EVT.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
00:09Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
